Valstar Solution, Concentrate
Product Images NDC 67979-001

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valstar (NDC 67979-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Chemical Structure Of Valrubicin (Valstar 1)

Chemical structure of valrubicin, the active ingredient in Valstar intravesical solution, concentrate 40 mg/mL by Endo USA, Inc. The structure shows the molecular framework with various functional groups attached.*

FDA Label Image

Figure 2. Comparison Of Mean Auc0-6 Hours In Valstar Clinical Studies (n=number Of Patients) (Valstar 2)

A bar graph comparing mean AUC values (0-6 hours) of total serum anthracyclines in different VALSTAR clinical study patient subsets. The x-axis lists patient subsets: Two Weeks After TUR 900 mg, Typical TUR 800 mg, Extensive TUR 800 mg, Perforated Bladder 800 mg, and IV Infusion 600 mg/m2. The y-axis shows total serum anthracyclines (nmoles/L/hr) ranging from 0 to 20,000. Bars vary significantly in height, with Perforated Bladder and IV Infusion subsets showing notably higher AUC values.*

FDA Label Image

Vial Label (Valstar 3)

Valstar (valrubicin) sterile solution for intravesical instillation 200 mg/5 mL (40 mg/mL) in a 5 mL single-use vial. The label includes storage instructions to refrigerate at 2°-8°C, warnings not to administer without diluting and not for IM or IV use, and notes that the product contains no preservative. Distributed by Endo Pharmaceuticals Inc., manufactured by BSP Pharmaceuticals S.p.A., Italy.*

FDA Label Image

Carton Image (Valstar 4)

Valstar 40 mg/mL (valrubicin) sterile solution concentrate for intravesical instillation in a 5 mL single-use vial. The label shows it is a cytotoxic agent manufactured by Endo USA, Inc., with product NDC 67979-001-01. The packaging includes usage and safety information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.